Stockreport

Blueprint Medicines inks deal with CStone Pharmaceuticals to develop and commercialize Avapritinib, BLU-554 and BLU-667 in China [Seeking Alpha]

Blueprint Medicines Corporation  (BPMC) 
Last blueprint medicines corporation earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: blueprintmedicines.com
PDF Blueprint Medicines inks deal with CStone Pharmaceuticals to develop and commercialize Avapritinib, BLU-554 and BLU-667 in ChinaBlueprint Medicines (NASDAQ:BPMC) and CSt [Read more]